Hallucinations, cognitive decline, and death in Alzheimer's disease

被引:51
|
作者
Wilson, RS
Tang, Y
Aggarwal, NT
Gilley, DW
McCann, JJ
Bienias, JL
Evans, DA
机构
[1] Rush Univ, Med Ctr, Armour Acad Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA
[2] Rush Univ, Med Ctr, Rush Inst Healthy Aging, Chicago, IL 60612 USA
[3] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA
[4] Rush Univ, Med Ctr, Dept Behav Sci, Chicago, IL 60612 USA
[5] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA
[6] Rush Univ, Med Ctr, Coll Nursing, Chicago, IL 60612 USA
关键词
Alzheimer's disease; longitudinal study; hallucinations; cognitive function; psychotic symptoms;
D O I
10.1159/000090251
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The relation of psychotic symptoms to cognitive decline and mortality in Alzheimer's disease ( AD) was examined during a mean of 2.2 years in 478 persons selected from clinical settings. Psychotic symptoms were ascertained at baseline and cognition was assessed semiannually with nine tests from which a global measure was formed. In analyses that controlled for age, sex, race, and education, hallucinations (29.6%), especially visual ones, were associated with more rapid global cognitive decline and increased mortality, even after controlling for baseline level of cognition and use of antipsychotic medication, and the association with mortality increased with higher level of education. Delusions and misperceptions were not strongly related to cognitive decline or mortality. The results suggest that hallucinations in Alzheimer's disease, particularly visual ones, are associated with more rapid progression. Copyright (C) 2006 S. Karger AG, Basel.
引用
收藏
页码:68 / 75
页数:8
相关论文
共 50 条
  • [1] Hallucinations, delusions, and cognitive decline in Alzheimer's disease
    Wilson, RS
    Gilley, DW
    Bennett, DA
    Beckett, LA
    Evans, DA
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 69 (02): : 172 - 177
  • [2] Cognitive Decline: Not Always Alzheimer's Disease
    Villalba, Noel Lorenzo
    Laboulbene, Stephane
    Merzouki, Tawoufik
    Mendez Bailon, Manuel
    Kechida, Melek
    Sigonney, Vanessa
    Teguo, Maturin Tabue
    [J]. JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2018, 2 (01) : 51 - 53
  • [3] Trajectories of cognitive decline in Alzheimer's disease
    Wilkosz, Patricia A.
    Seltman, Howard J.
    Devlin, Bernie
    Weamer, Elise A.
    Lopez, Oscar L.
    DeKosky, Steven T.
    Sweet, Robert A.
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2010, 22 (02) : 281 - 290
  • [4] Periodontitis and Cognitive Decline in Alzheimer's Disease
    Ide, Mark
    Harris, Marina
    Stevens, Annette
    Sussams, Rebecca
    Hopkins, Viv
    Culliford, David
    Fuller, James
    Ibbett, Paul
    Raybould, Rachel
    Thomas, Rhodri
    Puenter, Ursula
    Teeling, Jessica
    Perry, V. Hugh
    Holmes, Clive
    [J]. PLOS ONE, 2016, 11 (03):
  • [5] Cognitive Decline and Treatment of Alzheimer's Disease
    Ignacio Brusco, Luis
    [J]. NEUROPSYCHIATRIC DISORDERS, 2010, : 213 - 226
  • [6] Reversal of cognitive decline in Alzheimer's disease
    Bredesen, Dale E.
    Amos, Edwin C.
    Canick, Jonathan
    Ackerley, Mary
    Raji, Cyrus
    Fiala, Milan
    Ahdidan, Jamila
    [J]. AGING-US, 2016, 8 (06): : 1250 - 1258
  • [7] Cognitive decline and survival in Alzheimer's disease
    Wilson, RS
    Li, Y
    Aggarwal, NT
    McCann, JJ
    Gilley, DW
    Bienias, JL
    Barnes, LL
    Evans, DA
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 21 (04) : 356 - 362
  • [8] Antipsychotics, cognitive decline and death in Alzheimer's disease: the London and South-East Region Alzheimer's Disease longitudinal study
    Ames, D.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (01): : 2 - 2
  • [9] Predictors of cognitive and functional decline in Alzheimer's disease
    Mungas, D
    Reed, BR
    Jagust, WJ
    [J]. NEUROLOGY, 1999, 52 (06) : A436 - A437
  • [10] Cognitive decline in the prodromal phase of Alzheimer's disease
    Orgogozo, J. -M.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 24 - 24